Biomea Fusion Inc. (BMEA)
NASDAQ: BMEA
· Real-Time Price · USD
1.75
0.12 (7.36%)
At close: May 12, 2025, 3:59 PM
1.80
2.56%
After-hours: May 12, 2025, 07:33 PM EDT
7.36% (1D)
| Bid | 1.63 |
| Market Cap | 65.94M |
| Revenue (ttm) | 1.22M |
| Net Income (ttm) | -99.36M |
| EPS (ttm) | -3.54 |
| PE Ratio (ttm) | -0.5 |
| Forward PE | -0.58 |
| Analyst | Buy |
| Ask | 1.84 |
| Volume | 433,795 |
| Avg. Volume (20D) | 694,977 |
| Open | 1.70 |
| Previous Close | 1.63 |
| Day's Range | 1.67 - 1.80 |
| 52-Week Range | 1.53 - 13.43 |
| Beta | -0.08 |
About BMEA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BMEA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BMEA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
-16.5%
Biomea Fusion shares are trading lower after the c...
Unlock content with
Pro Subscription
4 months ago
+2.3%
Biomea Fusion shares are trading higher after the company announced new preclinical data from in vivo studies of icovamenib in combination with semaglutide.
